Astrana Health Stock (NASDAQ:ASTH)


ForecastRevenueFinancialsChartTranscripts

Previous Close

$49.81

52W Range

$18.08 - $51.60

50D Avg

$38.60

200D Avg

$28.94

Market Cap

$2.44B

Avg Vol (3M)

$576.62K

Beta

0.89

Div Yield

-

ASTH Company Profile


Astrana Health, Inc., which rebranded from Apollo Medical Holdings, Inc. in February 2024, is a healthcare management firm based in Alhambra, California, founded in 1985. This company delivers medical services throughout the United States, operating with a physician-centered approach powered by advanced technology. Its operations are structured across three distinct divisions: Care Partners, Care Delivery, and Care Enablement. Astrana Health utilizes its exclusive platform for population health management and healthcare delivery to implement an integrated, value-based care model. This strategic approach empowers the healthcare providers within its network to offer high-quality care to their patients. The organization provides extensive care coordination services to a broad spectrum of stakeholders, including patients, their families, primary care physicians, specialists, acute care hospitals, other inpatient facilities, physician groups, and health plans. Its robust physician network encompasses primary care doctors, specialized practitioners, advanced practice providers (extenders), and hospital-based physicians. Astrana Health serves a diverse patient base, primarily those with insurance coverage—such as private plans, Medicare, Medicaid, and HMOs—but also extends care to uninsured individuals.

Show More

Industry

Medical - Care Facilities

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

1,900

IPO Date

Mar 11, 2009

Website

ASTH Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24
Health Care, Other$86.20M$86.22M
Health Care Capitation Revenue$2.92B$1.86B
Health Care, Patient Service$112.64M$62.33M
Management Service$30.39M$13.98M
Product and Service, Other$28.28M$15.22M

Fiscal year ends in Dec 25 | Currency in USD

ASTH Financial Summary


Dec 25Dec 24Dec 23
Revenue$3.18B$2.03B$1.39B
Operating Income$78.53M$89.35M$84.61M
Net Income$22.49M$43.15M$60.72M
EBITDA$124.27M$141.84M$123.69M
Basic EPS$0.46$0.91$1.30
Diluted EPS$0.46$0.90$1.29

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 26May 08, 26 | 12:00 AM
Q4 25Mar 02, 26 | 8:30 AM
Q3 25Nov 06, 25 | 5:30 PM

Peer Comparison


TickerCompany
OMCLOmnicell, Inc.
SEMSelect Medical Holdings Corporation
USPHU.S. Physical Therapy, Inc.
ACHCAcadia Healthcare Company, Inc.
HCSGHealthcare Services Group, Inc.
MDPediatrix Medical Group, Inc.
AVAHAveanna Healthcare Holdings Inc.
LFSTLifeStance Health Group, Inc.
MNKDMannKind Corporation